




























































































a  coordinated  response  or  isolating  groups  of  cells  from  the  rest  of  the 
community  to  maintain  tissue  integrity  (Mese  et  al.  2007).  Contact-
independent  signaling  is  ideal  for  long-range  communication, while  contact-
dependent signaling is best suited for spatially localized rapid communication 
(Downward 2001). Gap junction intercellular communication(GJIC) represents 
an  important  class  of  contact-dependent  signaling.  In  vertebrates,  gap 
junctions  are  made  up  of  a  multi-gene  family  called  Connexins  (Cxs) 
(Willecke et al. 2002), whereas  invertebrate gap  junctions are encoded by a 
separate  gene  family  known  as  the  innexins  (Phelan  and  Starich  2001). 
Connexins  and  innexins  share  an  identical  membrane  topology,  but  little 
sequence homology  (Wei  et  al.  2004). Gap  junctions  (GJs)  are  intercellular 
membrane  channels  found  in  a  different  array  of  organisms  spanning  from 
nematodes, echinoderms, ascidians, mollusk, and arthropods  to vertebrates 
such  as  frog,  chick,  rodents,  and  humans.  Gap  junctions  are  specialized 
regions  of  the  plasma  membrane  in  which  hexameric  oligomers,  called 
connexons,  dock  end-to-end  non-covalently  across  the  narrow  extracellular 





ATP  and  ions  such  as  K+  (Goldberg  et  al.  2004).  Thus,  the  expression  of 
multiple Cx proteins  in  tissue  is  likely  to confer different properties  for GJ  in 
different cell types. The opening and permeability of GJs may be regulated by 




























                                      Figure1.Connexins jo int to  form connexon and connexons jo int  























all multicellular  organisms,  from mesozoa  to  humans  (Bruzzone  et  al. 
1996;  Gerido  and  White  2004),  including  a  putative  invertebrate 
connexin (Phelan et al. 1998; White 2003). In mammals connexin genes 
are  named  based  on  their  molecular  weight  in  Kilodaltons  (KDa) 
(Salameh and Dhein  2005).  Cxs genes are  classified  into  two groups 
based on  their  structure  and  sequence homology which  are α-  and β-
Cxs (HUGO Gene Nomenclature Committee HGNC, 2007) available at 
http://www.genenames.org/genefamily/gj.php).  Connexins  are  proteins 
that  have  four  transmembrane  domains,  two  extracellular  and  one 
intracellular loop, and allow the transfer of small molecules up to 1 KDa 
in size. Connexins are expressed in several tissues, but in many cases 
their  effects  are  restricted  to  particular  organs  and  mutations  in  a 
connexin  can  affect  one  organ  expressing  this  protein,  but  these 
mutations do not affect other tissues expressing the same protein. The 
exact  mechanism  for  this  selectivity  for  organ  involvement  is  actually 
unknown  and  it  can  only  partially  be  explained  by  redundancy  in 
connexin  expression  or  by  a  specific  regulation  at  the  transcriptional 
level as an alternative splicing.  Multiple Cx types are often expressed in 




al.  2001).  The  loss  of  one  Cx  protein  may  be  compensated  by  the 
function of others in specific tissues, however, the range of Cx mutations 
associated with disease illustrates that this is not always possible or that 
specific  mutants  may  ‘gain’  a  deleterious  function  in  specific  tissue 
(White 2003; Mese et al. 2007). For example, Cx26 is expressed in the 
cochlea,  skin,  lung  and  hepatocytes,  however  some  specific  loss  of 
function  Cx26  mutants  only  cause  deafness,  but  not  skin  or  other 
disease (Kelsell et al. 1997; Carrasquillo et al. 1997; Gerido and White 
2004).  After  gene  transcription,  Cxs  co-translationally  enter  the 
endoplasmic  reticulum  (ER),  however  Cx26  is  believed  to  enter  the 
organelle either co-translationally or after translation (Zhang et al. 1996). 
Cxs  are  not  glycosylated  but  is  hypothesized  to  be  assessed  by 
molecular chaperones and protein disulphide-isomerases residing in the 




at  different  cellular  locations  depending  on  the  Cx.  Hemichannels  are 






to move  laterally  towards existing GJ channels,  thus  forming  large gap 
junction  plaques.  Depending  on  the  cell  type  and  the  connexin 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expressed,  connexons  can  function  as  hemichannels,  forming a  direct 
transmembrane  communication  pathway,  enabling  the  permeation  of 





























Several connexins are  involved  in human pathologies  (Pfenniger et al. 
2011). It is actually reported that connexins 26, 29, 30, 30.3, 31, 32, and 
43 codified respectively by GJB2, GJE1, GJB6, GJB4, GJB3, GJB1 and 
GJA1  genes  are  involved  in  human  diseases  affecting  cochlea  and 
some  of  them  (Cx26,  Cx30,  Cx30.3,  Cx31  and  Cx43)  have  been 
involved  too  in  syndromic  form  of  hearing  loss  affecting  cochlea  in 
combination  with  epidermis  (Rouan  et  al.  2001;  López-Bigas  et  al. 
2002).  In  particular,  the  GJB2  gene  that  encodes  the  connexin  26 




embryonically  lethality  at  embryonic 11-day  (ED)  (Gabriel et  al.  1998). 
These  data  suggested  that  this  was  due  to  defective  glucose  uptake 
because  the  embryos  were  smaller  but  did  not  display  any  other 
abnormalities.  This  contrasts  to  the  human  phenotype  of  GJB2 
mutations leading to deafness, many of the most frequent of which lead 
to  the  introduction  of  a  nonsense  (stop)  codon  and  thus  a  truncated 
protein. For example, c.35delG leads to a frameshift and creates a stop 
codon at position 30-35. The  targeted disruption of mGjb2  in  the  inner 
ear  of  mice  only  and  revealed  that  high  levels  of  cell  death  occurred 

































The  structure  of  the  GJB2  gene,  as  well  the  structure  of  other  gap 
junction  genes,  is  simple.  An  untranslated  exon  1  is  separated  by  an 
intron  of  3179  bp  length  from  exon  2,  containing  the  uninterrupted 
coding  region  and  the  3'  untranslated  region  (3'UTR)  (figure2  ).  GJB2 
gene  encodes  Cx26  protein,  that  consists  of  four  alfa-helical 
transmembrane domains (TM1–TM4), two extracellular loops (EC1 and 
EC2),  a  cytoplasmic  aminoterminal  domain  (IC1),  a  cytoplasmic  loop 
(IC2)  between  TM2  and  TM3,  and  a  carboxy-terminal  (IC3)  domain 
(Evans  and  Martin  2002)  (figure3).  The  two  latter  domains  are 
characteristic of each connexin, while  the membrane spanning and the 
extra  cellular  domains  are  highly  conserved  among  the  entire  protein 
family (Mese et al. 2007; Goodenough et al.1996). Under physiological 
conditions  the  extra  cellular  portions  of  a  connexon  interact  with  a 
connexon  of  opposing  cell  in  the  intercellular  space  to  complete 
functional active channels. The cytoplasmic loop and the N-terminus of 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Structure of GJB2 gene: the gene conta in two exons but only encoding 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Cx26 protein  is expressed  in several  tissues (Gerido and White 2004). 
In the skin the expression of Cx26 is restricted to hair follicles and sweat 
glands  in  interfollicular  skin  (Labarthe  et  al.  1998;  Common  et  al. 
2005a). Low levels are found in the basal layer and granular layer (Di et 
al. 2001) of palmoplantar  (palm and sole) skin. Cx26 was  found  to be 
upregulated  behind  the  wound  edge  after  injury,  implicating  Cx26  in 
keratinocyte  migration  into  the  wound  and  thus  in  the  wound  healing 
process (Coutihno et al. 2003). In the inner ear the Cx26 protein is found 
in  nonsensory  epithelial  cells  surrounding  the  hair  cells, which  include 
supporting  cells  of  the  organ  of  Corti,  inner  sulcus  cells,  outer  sulcus 
cells, and interdental cells of the spiral limbus. Cx26 is also expressed in 
connective  tissue  cells  of  the  cochlea  including  strial  basal  cells,  strial 
intermediate  cells,  mesenchymal  cells  lining  the  scala  vestibuli,  and 
fibrocytes  in  the  spiral  limbus and  spiral  ligament. Even  if Cx26  is not 
expressed  in hair cells, Cx26 expression  in  the  inner ear  is believed to 
play a major role in the formation of gap junction system. 
Both  dominant  and  recessive  mutations  in  GJB2  are  linked  to 
Neurosensorial  Hearing  Loss  (NSHL).  All  GJB2  mutations  associated 
with  syndromic  diseases  discovered  to  date  are  dominant  and  the 
majority of these are found in the NT (N-terminal) and ELs (Extraloops). 












affects  millions  of  people  all  over  the  world  and  is  the most  common 
connexin-related disease. Hearing  loss comprises a broad spectrum of 
clinical presentation; approximately one child  in 650  is born deaf  (Mehl 
and Thomson 2002) and in many cases the cause cannot be identified 
and  frequently  it  will  be  diagnosed  as  idiopathic.  The  genetic  causes 
account  for 50–60 % of childhood deafness. Usually, genetic deafness 
may be an  isolated disorder,  in  the  form of non-syndromic HL (NSHL), 
although  frequently  associated  with  other  dysfunction.  Genetic  HL  is 
present  also  in  the  form  of  syndromic  HL  (SHL),  where  deafness  is 
associated with other phenotypes such as blindness (Usher Syndrome), 
goiter  (Pendred  Syndrome)  or  nephritis  (Alport  Syndrome)  or 
keratoderma.  Among  the  syndromic  forms  there  are  also  different 
manifestations  of mental  retardation  that  involve  deafness. During  the 
last 15 years, about 65 of  the genes responsible  for hearing  loss have 
been  identified  (Hereditary  Hearing  Loss  Homepage, 
http://hereditaryhearingloss.org/).  Several  studies  demonstrated  that 
Cx26  codified  by  the  GJB2  gene  (Gap  Junction  Protein,  Beta  2) 




are  apparently  sporadic  in  origin  (Estivill  et  al.  1998)  as  well  as  in 
dominant  form  of  hearing  loss  (Denoyelle  et  al.  1998).  However,  the 
mutation  spectrum  in  GJB2  varies  among  populations  with  different 
ethnic  backgrounds.  More  than  100 mutations  have  been  reported  in 
GJB2  (The  Connexin-deafness  homepage:  http://davinci.crg.es/ 
deafness),  which  can  be  broadly  divided  into  truncating  and  non-
truncating mutations (Kelsell et al. 1997). No clear genotype–phenotype 
correlation  is present but  truncating mutations are generally associated 
with  a  greater  degree  of  hearing  loss  than  non-truncating  mutations 
(Snoeckx  et  al.  2005;  Cryns  et  al.  2004).  Truncating  GJB2 mutations 
include  nonsense,  splice,  and  frame  shift  mutations,  and  result  in 
defective protein synthesis. The most common mutation is a deletion of 
a  single  guanine  nucleotide,  known  as  c.35delG,  which  results  in  a 
frameshift  mutation  with  premature  termination  of  protein  translation 
(Denoyelle  et  al  2000;  Lerer  et  al.  2001).  Non-truncating  mutations, 
which  include  deletions  and  insertions,  and  missense  mutations,  can 
affect  connexin  function,  depending on  the  position  and  type of  amino 
acid  substitution.  Recessive GJB2 mutations  in  regions  coding  for  the 
amino-terminus, may reduce cell membrane stability  (Thonnissen et al. 
2002;  Nickel  and Forge  2008),  nonfunctional  or  altered  voltage  gating 









Inherited  NSHL  is  categorized  according  to  whether  it  is  autosomal 
dominant (DFNA), autosomal recessive (DFNB) or X-linked (DFN), with 
80% of cases being attributed  to DFNB  forms  (Petit et al. 2001). Over 
100  loci  have  been  implicated  in  causing  hearing  loss  (Ballana  et  al. 
2010)  however  GJB2  mutations  account  for  about  50%  of  prelingual 
genetic  NSHL  in  Caucasians  (Gasparini  et  al.  2000),  (Rabionet  et  al. 
2000; Petit et al. 2001; Liu et al. 2002; Pandya et al. 2003). The majority 
of GJB2 mutations linked to deafness are recessive. Some of the most 
common  recessive  GJB2  mutations  associated  with  NSHL  appear  to 
affect  the  ability  of  the  protein  to  form  functional  GJs,  and  hence  are 
described  as  loss  of  function mutants  (White  2000),  (Bruzzone  et  al. 
2003b).  For  example,  c.35delG  (also  called  c.30delG)  results  in  the 
deletion of a guanine in a stratch of six guanines, leading to a frameshift 
after  codon  12  and  a  premature  stop  codon,  resulting  in  a  severely 
truncated Cx26 protein (Zelante et al. 1997). GJs have been implicated 
in  enabling  the  flow  of  K+  from  sensory  hair  cells  to  the  cochlear 
endolymph (Kikuchi et al. 1995) and it has been hypothesised that Cx26 
mutants  linked to NSHL, due  to  their  inability  to  form  functional GJs  in 
the  cochlea,  disrupt  K+  transport  (Rabionet  et  al.  2000;  Kudo  et  al. 
2003). This appears to lead to degeneration of sensory hair cells in the 
inner  ear  and  indicates  that  other  Cxs  expressed  there  cannot 
compensate  for  the  loss  of  normal  Cx26  function  (Kudo  et  al.  2003). 
Although  resulting  in  deafness,  NSHL mutations  such  as  c.35delG  do 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Homozygosity  mapping  in  two  Tunisian  consanguineous  families 
performed by Guilford et al. (1994) demonstrated linkage of DFNB to a 
locus on  chromosome 13q11,  termed DFNB1. This  region was  further 
reduced  by  Gasparini  et  al.  (1997).  Kelsell  et  al.  (1997)  screened  a 
candidate  gene  in  this  region,  GJB2,  and  discovered  the  nonsense 
mutations  in  two  different  families  with  recessive  NSHL  which 
segregated  with  disease.  More  than  90  recessive  GJB2  mutations 
associated  with  NSHL  have  been  discovered  to  date,  the  full  list  of 
which  can  be  found  on  the  Connexin-deafness  homepage 
(http://davinci.crg.es/deafness)  (Ballana et al. 2010). Of  the  total GJB2 
NSHL  mutations  reported  to  date,  only  a  few  of  these  have  a  high 
















Although  mutations  implicated  in  dominantly  inherited  hearing 
impairment  are  not  as  common  as  those  implicated  in  recessively 
inherited hearing impairment, a few DFNB1 mutations have been related 
to  dominantly  inherited  hearing  impairment,  both  non-syndromic  and 
syndromic  form. Several GJB2 mutations have been  identified  that can 
cause nonsyndromic deafness. This type of inheritance means that one 
copy of  an  altered GJB2 gene  is  sufficient  to  cause hearing  loss. The 
altered gene  instructs  the  incorrect  replacement of a single amino acid 
(the building material of proteins) in the Cx26 protein. The effect of these 
dominant  mutations  remains  unclear.  The  altered  protein  probably 



















syndromic  forms  of  hearing  loss  associated  to  skin  problems,  which 
show all an autosomal dominant pattern of transmission. As well as for 
the  hearing  loss,  the  clinical  phenotypes  associated  have  a  large 
variability  and  the  phenotypic  variability  is  observed  even  among 
carriers of the same connexin mutation (Heathcote et al. 2000; Uyguner 
et al. 2002). Syndromic HL associated with GJB2 mutations include the 
‘classical’  form  of  Vohwinkel  syndrome  (VS),  Keratitis-ichthyosis-
deafness  (KID)  syndrome,  Bart-  Pumphrey  syndrome  (BPS), 




in  the  NT  or  EC1  of  the  protein.  Certain  mutations  can  give  rise  to 
different  syndromes,  illustrating  the  heterogeneous  presentation  and 
clinical  overlap  between  the  syndromes.  Functional  studies  have 
indicated  that  Cx26  syndromic  mutants  gain  an  aberrant  function  in 
certain  tissue and have a dominant negative effect on other Cxs or on 
other proteins  in  the cell  (Mese et al. 2007; Lee and White 2009). The 
Palmoplantar  Keratoderma  is  a  syndromic  form  of  deafness  (mild  to 
profound).  Hereditary  Palmoplantar  Keratoderma  (PPK)  comprise  a 
clinically  and  genetically  heterogeneous  group  of  genodermatoses, 
which  share  impaired  epidermal  differentiation  resulting  in  prominent 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palmoplantar  hyperkeratosis.  Classically,  keratoderma  has  been 
separated according  to  their clinical appearance  into diffuse,  focal, and 

























function  are  controlled  by  almost  100  genes  and  the  hearing  loss  of 
genetic basis can be caused by a wide variety of mutations in different 
genes.  So  far  has  been  identified  about  65  genes  responsible  for 
various  forms  of  hereditary  deafness. Many others  have  not  yet  been 
identified,  and  for  this  reason  at  the  time  is  not  always  possible,  in 
subjects suffering, define the specific form of deafness and identify DNA 
alteration  (mutation)  responsible  for  the  pathology.  Mutations  in  Cx 
genes  have  been  implicated  in  a  range  of  diseases  phenotypes.  The 
aims  of  this  study,  through  analysis  of  some  gene  responsible,  is  to 
understand  the pathophysiological mechanism underlying hearing  loss, 
to  characterize  by  functional  assays  novel  variations  identified  in  the 
analyzed genes in order to clarify whether or not the identified variation 
are  responsible  of  disease  phenotype,  and  to  effectuate  a  genotype-






























Adults  patients  underwent  audiological  evaluation  by  pure-tone 
audiometry,  tympanogram, and acoustic  reflex  testing  in both ears. To 
measure  hearing  loss  severity,  the  air  conduction  pure  tone  average 
(PTA)  of  both  ears was  computed using  four  frequencies  (500,  1,000, 
2,000,  and  4,000  Hz)  according  to  the  better  ear.  Hearing  loss  was 
categorized according to the guidelines of the European work group on 
Genetics of Hearing Loss: 21-40 dB as mild, 41-70 dB as moderate, 71-
95  dB  as  severe,  and  more  than  95  dB  as  profound  (GENDEAF, 
European  Thematic  Network  on  Genetic  Deafness).  The  clinical 
evaluation  for  children  provides  a  diagnostic  protocol,  performed 
according  to  international  standards  (Declau  et  al.  2005)  includes: 
transient  evoked  otoacustic  emissions  (TEAOE),  click-evoked  testing 
auditory  brainstem  response  (ABR),  measurement  of  auditory  steady 
state  responses  (ASSR)  and  impedance  test.  For  ABR  recordings,  a 
replicable  waveform  at  50  dB  SPL  within  the  expected  latencies  was 
considered  “normal”.  Syndromic  forms  of  hearing  loss were  evaluated 












from  peripheral  blood  samples  obtained  in  EDTA-containing  tubes  or 
from  saliva  (buccal  swabs)  (Gentra  System,  DNA  Isolation  Kit).  The 
presence of GJB2 mutations was ascertained through direct sequencing 
of amplified PCR fragments of the coding region (exon 2) of GJB2 gene. 
The  subjects who  are  negative  or  single  heterozygote  for GJB2  gene 
mutation  were  analyzed  for  GJB3  and  GJB6  genes  mutation.  In 
particular  the  presence  of  GJB3  mutations  was  ascertained  through 
direct  sequencing of  amplified  PCR  fragments  of  the  coding  region  of 
GJB3 gene;  instead,  for GJB6 gene, was evaluated by multiplex PCR 

















using  oligonucleotide  primers  that  introduced  EcoRI  and  BamHI 
restriction  enzyme  sites  at  the  5′  and  3′  termini  of  the  cDNAs, 
respectively,  deleting  the  stop  codon:  Cx26for:  5’-
CGGAATTCAGATGGATTGGGGCACG-3’  and  Cx26rev:  5’-
CGGGATCCACTGGCTTTTTTGACTT-3’.  The  resulting  PCR  products 
were digested with the two enzymes and ligated into the EcoRI–BamHI 
sites  of  pEYFP-N1  (Clontech,  Palo  Alto,  CA)  (figure4)  followed  by 
transformation  into  Escherichia  coli  (TOP10).  Miniplasmid  preparation 
and  restriction  enzyme  analysis  were  performed  to  identify  positive 
clones.  All  clones  were  sequenced  as  recommended  by  the 












Cx26  mutation  (p.G130V)  was  introduced  into  the  wild-type  cDNA  of 
Cx26  using  a  site-directed  mutagenesis  kit  according  to  the 
manufacturer’s  instructions  (Stratagene)  using  the  same  primers  that 
introduced EcoRI and BamHI restriction enzyme sites (see above). The 
resulting PCR products were digested with the two enzymes and ligated 
into  the  EcoRI  –BamHI  sites  of  pEYFP-N1  (Clontech,  Palo  Alto,  CA) 
(figure4) followed by transformation into E. coli. Miniplasmid preparation, 


























The  human  HeLa  cell  line  devoid  of  Cxs  has  been  widely  used  for  GJ 
functional  studies.  HeLa  cells  were  grown  in 
Dulbecco’s Modified Eagle’s Medium  (DMEM)  with  1000  mg  glucose/L, 
NaHCO3  and  pyridoxine-HCl  supplemented  with  10%  Fetal  Bovine  Serum 
(Thermo  Scientific  HyClone),  L-Glutamine  and  1%  Penicillin  10.000U/mL-
Streptomycin 10mg/mL  (Sigma Aldrich). HeLa cells were  incubated at 37°C 
according to standard procedures. At 24 h after plating on cover glass (25mm 




























                                                          
 
 


























As  reported  in  literature,  the  carrier  rate  of  certain  recessive GJB2 NSHL 
mutants  worldwide  is  relatively  high  at  1-3%  with  different  prevalence  in 
specific  ethnic  groups,  for  example,  c.35delG  has  a  high  frequency  in 
European countries (Denoyelle et al. 1997; Gasparini et al. 2000; Meyer et 
al. 2002; Common et al. 2004). 
 During  this work we analyzed 806  subjected affected by  hearing  loss  for 
GJB2  mutations.  Among  affected  subjects,  23%  (187/806)  carried 
mutations  in  GJB2  gene.  In  particular  we  identified  70/187  subjects 
c.35delG  homozygotes,  33/187  subjects  c.35delG  heterozygotes,  35/187 
subjects  compound  heterozygotes  c.35delG/other,  11/187  subjects 
compound  heterozygotes  with  both  mutations  non  c.35delG  and  38/187 
heterozygotes subjects with other mutation different to c.35delG (figure4 ). 
Thus,  we  obtained  a  clear  etiological  diagnosis  for  14%  (116/806)  of  the 
subjects  for  which  we  can  say  that  hearing  loss  is  caused  by  genetic 
factors.  Moreover,  different  new  mutations  [G4V  (c.11G>T),  D159S 
(c.478G>A),  M195T  (c.584T>C)]   were  identified  during  this  study  which 
have  not  yet  been  characterized  from  a  functional  point  of  view. 
Interestingly our study revealed a family carrying a mutation described only 
one times until now (Snoeckx 2005), the p.G130V (c.389G > T) mutation in 
the GJB2 gene.  In  this  family  both NSHL and Palmoplantar  Keratoderma 
(PPK) are present. The mutational analysis  in  the GJB2 gene, revealed  in 
the  propositus  (III-1)  (figure5)  the  presence  of  the  mutation  c.35delG  in 
compound  heterozygosis  with  the  mutation  c.389G>T.  The  mutation 
p.G130V  is  heterozygous  in  the  propositus’  affected  mother  (II-1)  and 
grandfather  (I-1),  indicating  an  autosomal  dominant  transmission.  The 
unaffected  father  (II-2)  carries  the  c.35delG mutation  in  the  heterozygous 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state. We realized functional studies to identified whether p.G130V mutation 
alter  connexin  trafficking  and  gap  junctions  formation.  When  HeLa  cells 
were  transiently  transfected  with  Cx26-GFP  wt,  intercellular  gap  junction 
plaques were detected at points of cell-to-cell contact with limited punctate 
staining  near  the  nuclei  (figure6).  Moreover,  in  HeLa  cells  transiently 
transfected  with  pG130V-GFP,  also  the  mutant  fusion  protein  had  a 
predominantly  membrane  localization,  (figure7)  demonstrating  that  the 
mutation do not alter protein trafficking and gap junction formation.  
In  our work we have also  analyzed a  family  affected by  a  form of mental 
retardation with deafness. Before arriving at the Unit of Audiology this family 
had  already  been  subjected  to  some  investigation  as metabolic  analysis, 
molecular  analysis  for  X-fragile  (FRAX-A)  and  caryotype  analyses.  The 
genealogic  tree evaluation suggested a genetic condition with an X-linked 
transmission (figure8). The proband (subject IV-1), analyzed at five months 
of  age,  presented  a  severe  form  of  bilateral  neurosensorial  hearing 
impairment.    Molecular  screening  for  GJB2  gene  mutations  resulted 
negative. The subjects was also screened for the presence of the deletions 
upstream  the  GJB6  gene  involved  in  digenic  forms  of  hearing  loss  with 
GJB2  (Del  Castillo,  2005).  Successively,  at  about  two  years  of  age,  the 
proband  (subject  IV-1)  presented  several  sign  of  neuropsicomotor  delay 
with  some  peculiar  characteristics  of  the  face  (broad  forehead,  palpebral 
fissure turned down, wide ears). The younger brother too (subject IV-2) and 
the  other affected  subjects  (III-3,  III-V)  presented  similar  characteristics  of 
hearing  impairment  and  neuropsicomotor  delay  but,  with  a  lesser 
seriousness. Peculiar characteristics of the face are absent. In the affected 
members,  metabolic  analysis,  molecular  analysis  for  X-fragile  (FRAX-A) 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and  caryotype  analyses  resulted  normal.  The  CGH-array  technique 
revealed a big deletion of about 5Mb on  the X-chromosome  in  the  region 
spanning between Xq21.1- Xq31.1 containing the POU3F4 gene involved in 
hearing  loss. Moreover,  to  obtain  information  useful  for  a  clear  genotype-
phenotype correlation, all  the affected subjects and the unaffected carriers 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sensorineural  hearing  loss  in  806  SNHL  individuals,  essentially  from 
Campania  region  (Southern  Italy),  was  determined.  In  particular  by 
using  a molecular  screening  for  GJB2,  GJB6  and GJB3  in  Campania 
region affected  subjects,    a  genetic  etiology has been  reached  for  the 
14% (116/806) of analyzed subject. From a point of view of genotype-
phenotype  correlation,  we  can  say  that  the  individuals  who  have  the 
mutation  c.35delG  in  homozygosis,  have  a  more  severe 
phenotype(figure9)  than  35delG/other  double  heterozygous  or 
homozygous  for  other  mutations(figure10).  Moreover,  the  molecular 
screening  has  allowed  to  reveal  an  interesting  family  in  which  both 
NSHL  and  Palmoplantar  Keratoderma  (PPK)  are  present.  This  family 
carries p.G130V mutation, confirming the involvement of the mutation in 
skin  abnormalities  but  with  different  expressivity.  In  fact  the  p.G130V 
mutation  in  GJB2  gene  was  described  by  Snoeckx  et  al,  in  a  family 
affected  by  Vohwinkel  Syndrome,  an  autosomal  dominant 
genodermatosis  characterized  by  three  clinical  findings:  diffuse 
honeycomb-like  keratotic  thickening  of  the  palms  and  soles,  starfish-
shaped  keratotic  plaques  on  the  dorsal  hands  and  feet,  and  fibrous 
constricting  bands  (pseudoainhum)  at  the  interphalangeal  joints  of  the 
hands and feet, which may result in autoamputation. In our family typical 
symptoms  of  the  Vohwinkel  Syndrome  are  not  present  but  the  three 
individuals  carrying  the mutation  are  all  affected  by  hearing  loss,  but 
none of  the dermatological characteristic signs of Vohwinkel Syndrome 
are  present.  Two  subjects  suffer  only  from  a  mild  Palmoplantar 
Keratoderma. The peculiarity of the p. G130V mutation is its localization 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in  the  second  intracellular  domain  (IC2),  whereas  most  of  dominant 
mutations involved in syndromic form of hearing loss are localized in the 
first  extracellular  domain  (EC1)  of  the  Cx26  protein.  This  mutation 
seems  originate  two  different  clinical  manifestation  (PPK  and  VS)  as 
observed  in  two  different  families.  Until  now,  for  this  mutation  there 
aren’t functional studies. The functional studies described  in this thesis 
try  to  evaluate  the  pathophysiological  role  of  p.G130V  mutation    and 
revealed  that  there  are  no  alteration  in  the  protein  trafficking  or  gap 
junction formation. Actually, we have not yet information on ionic current 
flow,  but  experiments  through  dual  patch-clamp  to  evaluate  the 
electrophysiological data are in progress. Moreover, to verify cytoplamic 
membrane  co-localization  of  wild  type  and  mutant  proteins  we  are 
cloning  the wt connexin protein  in a vector expressing (pDSred-vector) 
the  fusion protein  in a different color  from the previous (pEYFP-vector) 
we  used.  This  construct  will  be  co-transfected  with  the  previous 
described  in  order  to  evaluate  whether  the mutated  protein  is  able  to 
form mixed connexons with the wt protein and we would  like  to realize 
an  electrophysiological  study  in  order  to  assess whether  the mutation 
alters the ionic flow. In the future, we would to perform functional studies 
on  the new other variations  too,  identified by us. As regards  the  family 
affected  by  mental  retardation  and  deafness,  several  studies  suggest 
that  Mental  Retardation  X-Linked  (XLMR)  is  a  very  heterogeneous 
condition  and  to  date  more  XLMR  genes  have  been  identified.  The 
mutations in most of these genes give rise to syndromic forms of XLMR 
where the developmental delay is accompanied by behavioral, somatic, 
metabolic  or  neurological  disorders  (Hildebrand,  2007;  Rejeb,  2011). 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Between  neurological  disorders  frequently  is  reported  sensorineural 
hearing  impairment    (Liu 2010).  In  the  family  that manifests syndromic 







breakpoints.  Moreover,  we  will  realize  an  exhaustive  bioinformatics 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